<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ivancevic A</submitter><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>eado1218</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC466953</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(29)</volume><pubmed_abstract>Cancer cells exhibit rewired transcriptional regulatory networks that promote tumor growth and survival. However, the mechanisms underlying the formation of these pathological networks remain poorly understood. Through a pan-cancer epigenomic analysis, we found that primate-specific endogenous retroviruses (ERVs) are a rich source of enhancers displaying cancer-specific activity. In colorectal cancer and other epithelial tumors, oncogenic MAPK/AP1 signaling drives the activation of enhancers derived from the primate-specific ERV family LTR10. Functional studies in colorectal cancer cells revealed that LTR10 elements regulate tumor-specific expression of multiple genes associated with tumorigenesis, such as &lt;i>ATG12&lt;/i> and &lt;i>XRCC4&lt;/i>. Within the human population, individual LTR10 element</pubmed_abstract><journal>Science advances</journal><pubmed_title>Endogenous retroviruses mediate transcriptional rewiring in response to oncogenic signaling in colorectal cancer.</pubmed_title><pmcid>PMC466953</pmcid><funding_grant_id>R37 CA261987</funding_grant_id><funding_grant_id>T32 GM142607</funding_grant_id><funding_grant_id>R35 GM128822</funding_grant_id><pubmed_authors>Joyner OM</pubmed_authors><pubmed_authors>Bagby SM</pubmed_authors><pubmed_authors>Nguyen LL</pubmed_authors><pubmed_authors>Chuong EB</pubmed_authors><pubmed_authors>Ivancevic A</pubmed_authors><pubmed_authors>Simpson DM</pubmed_authors><pubmed_authors>Bitler BG</pubmed_authors><pubmed_authors>Pitts TM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Endogenous retroviruses mediate transcriptional rewiring in response to oncogenic signaling in colorectal cancer.</name><description>Cancer cells exhibit rewired transcriptional regulatory networks that promote tumor growth and survival. However, the mechanisms underlying the formation of these pathological networks remain poorly understood. Through a pan-cancer epigenomic analysis, we found that primate-specific endogenous retroviruses (ERVs) are a rich source of enhancers displaying cancer-specific activity. In colorectal cancer and other epithelial tumors, oncogenic MAPK/AP1 signaling drives the activation of enhancers derived from the primate-specific ERV family LTR10. Functional studies in colorectal cancer cells revealed that LTR10 elements regulate tumor-specific expression of multiple genes associated with tumorigenesis, such as &lt;i>ATG12&lt;/i> and &lt;i>XRCC4&lt;/i>. Within the human population, individual LTR10 element</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2026-04-30T00:08:50.071Z</modification><creation>2025-04-04T15:03:05.435Z</creation></dates><accession>S-EPMC466953</accession><cross_references><pubmed>39018396</pubmed><doi>10.1126/sciadv.ado1218</doi></cross_references></HashMap>